NRAS Q61H Protein, Human, Recombinant, Biotinylated
N-terminal AviTag™, N-terminal 6XHis
High-purity NRAS Q61H protein optimized for AlphaScreen, SPR, BLI, ELISA, pull-down, MST and oncology drug discovery applications.
Available Sizes
Product Overview
The recombinant NRAS Q61H protein is designed for high-confidence binding and interaction studies. This construct is site-specifically biotinylated at the N-terminus for surface-based assays.
This mutation is clinically relevant and widely used in oncology and targeted therapy research.
Key Features
- NRAS Q61H clinically relevant mutation
- N-terminal AviTag™, N-terminal 6XHis tagged construct
- Site-specifically biotinylated at the N-terminus
- High purity recombinant protein
- Optimized for binding assays
- Research Use Only (RUO)
Applications
- AlphaScreen
- SPR
- BLI
- ELISA
- Pull-down
- MST
- Protein–protein interaction studies
- Drug discovery workflows
Biological Context & Applications
Cancer Indications
Cutaneous melanoma, Mucosal melanoma, Colorectal cancer (CRC), Acute myeloid leukemia (AML), Multiple myeloma, Papillary thyroid carcinoma, Rhabdomyosarcoma, Non-small cell lung cancer (NSCLC), Histiocytic sarcoma, Diffuse large B-cell lymphoma (DLBCL)
Binding Partners
BRAF, RAF1 (CRAF), ARAF, RALGDS, RGL2, RASSF5 (NORE1), PLCε (PLCE1), PI3K, NF1
Application Notes
Oncogenic NRAS Q61H mutant with impaired GTP hydrolysis, associated with sustained RAS signaling and activation of the RAF–MEK–ERK (MAPK) pathway. Suitable for effector binding studies, inhibitor screening, and biochemical characterization of RAS pathway interactions. Site-specific biotinylation enables oriented immobilization on streptavidin-coated surfaces for SPR, BLI, and pull-down assays.
Protein Specifications
| Gene | NRAS |
|---|---|
| Mutation | Q61H |
| Organism | Human |
| Tag | N-terminal AviTag™, N-terminal 6XHis |
| Expression System | E. coli |
| Purity | >90% by Coomassie staining |
| Endotoxin | <1 EU/mg |
| Biotinylated | Yes |
| Oncogenic Status | Oncogenic |
| Assay Compatibility | AlphaScreen, SPR, BLI, ELISA, Pull-down, MST |
| UniProt ID | P01111 |
| Amino Acid Range | 1-189 |
| Buffer | 20 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 1 mM 2-mercaptoethanol, 10% glycerol |
| Storage | -80 °C |
Quality Control
- Purity validated by SDS-PAGE
- Identity confirmed by mass spectrometry
- Assay compatibility verified
- A Certificate of Analysis (CoA) is provided with every shipment
Ordering Information
| Size | Catalog No. | Price | Quote |
|---|---|---|---|
| 0.1 mg | NRAS61H-B-301-1 | $ 800.00 | Request Quote |
Typical response time: 1 business day
Custom Services
Need a different format, mutation, or production scale? We offer custom RAS protein engineering tailored to your research.
Alternative NRAS variants, including rare and novel mutations.
His-tag, AviTag™, biotinylation, fluorescent labeling, or tag-free formats.
From research-scale to bulk manufacturing for screening and preclinical work.
Complex formation such as NRAS–RAF-RBD and other binding partners.
Pre-load NRAS proteins with defined nucleotides, including GppNHp (non-hydrolyzable GTP analog) or GDP, for consistent assay-ready performance.
Tell us your mutation, format, or assay requirements and we’ll provide a tailored quote.
Fast turnaround • Dedicated scientific support • Confidential projects
Research Use Only. Not for diagnostic or therapeutic use.